The global veterinary biologics market is poised for significant growth, with its valuation estimated at USD 13,140.6 million in 2024 and projected to surpass USD 24,224.3 million by 2034. This represents a robust compound annual growth rate (CAGR) of 6.3% over the forecast period, highlighting the increasing demand for biologics in veterinary care.
Veterinary biologics, including vaccines, antibodies, and diagnostic tools, are becoming essential in addressing animal health concerns and preventing the spread of zoonotic diseases. The market’s growth is fueled by the rising adoption of companion animals, expanding livestock industries, and heightened awareness of animal healthcare. Additionally, the shift toward advanced biotechnological solutions is driving innovation in the field.
Emerging economies are expected to play a significant role in market expansion, with increasing investments in veterinary infrastructure and the growing penetration of biologics in rural and underserved areas. These factors, combined with government initiatives to enhance animal health standards, are creating lucrative opportunities for key players in the industry.
As the market evolves, leading companies are focusing on product development and strategic collaborations to strengthen their presence. The veterinary biologics market’s promising trajectory underscores its vital role in safeguarding animal health and supporting the broader ecosystem of public health and food security.
Key Highlights
- The increasing demand for specialized biologics for companion animals, including dogs, cats, and horses, presents a significant market opportunity. Companion animal healthcare has become a focus area for veterinary biologics manufacturers.
- The emergence of new and evolving infectious diseases in animals, such as avian influenza and African swine fever, creates opportunities for the development of specific vaccines and biologics to prevent and control these diseases.
- There is an increased focus on the health of animals to meet international standards, as trade in animal products becomes more globalized, which drives the demand for effective veterinary biologics to ensure the health and safety of animals in different regions.
- Increasing awareness among veterinarians, farmers, and pet owners about the benefits of preventive healthcare and the availability of veterinary biologics has a positive impact on market growth. Education campaigns and training programs play a crucial role in promoting the adoption of these products.
Key Growth Drivers
- Increasing Awareness of Animal Health: There is a growing recognition of the importance of animal health and welfare, which is driving demand for effective veterinary biologics, including vaccines and diagnostic kits.
- Regulatory Support: Enhanced regulations surrounding animal health and safety are fostering the development and adoption of veterinary biologics.
- Emerging Applications: The exploration of regenerative medicine in veterinary healthcare is opening new avenues for biologics aimed at tissue repair and regeneration.
Competitive Landscape
The veterinary biologics industry is a dynamic and competitive sector within the broader animal health industry. The market encompasses a wide range of biologically derived products designed for the prevention and treatment of diseases in animals.
The competitive landscape is characterized by the presence of established pharmaceutical companies, biotechnology firms, and specialized veterinary product manufacturers. The detailed note provides a comprehensive analysis of the competitive dynamics, key players, strategic initiatives, and market trends within the market.
Company Portfolio
- Zoetis Inc., as a leading player in the animal health industry, boasts a diverse portfolio of veterinary biologics, including vaccines, diagnostics, and other biological products. The global presence of the company and focus on innovation contribute to its prominent position in the market.
- Merck’s animal health division is a major player in the veterinary biologics market. The company offers a wide range of vaccines and biologic solutions for companion animals and livestock. The commitment of the company to research and development strengthens its competitive standing.
Key Veterinary Biologics Market Players
- Elanco Animal Health
- Ceva
- Phibro Animal Health Corporation
- Boehringer Ingelheim
- Zoetis Inc.
- Merck & Co. Inc.
- Virbac
- Hester Biosciences Limited
- Colorado Serum Company
- Addison Biological Laboratory Inc.
- American Animal Health Inc.
- HIPRA
- Bimeda Inc. (Texas Vet Lab Inc.)
Full Report Revealed
Key Segments in the Veterinary Biologics Market Report
By Product:
- Vaccines
- Attenuated Live Vaccines
- Conjugate Vaccines
- Inactivated Vaccines
- Subunit Vaccines
- Toxoid Vaccines
- DNA Vaccines
- Recombinant Vaccines
- Bacterial Extracts
- Monoclonal Antibody
- Immunomodulatory
- Cytokines
- Others
- Allergenic Extracts
By Animal:
- Companion Animals
- Canine
- Avian
- Feline
- Livestock
- Aquatic
- Bovine
- Porcine
- Ovine/Caprine
- Poultry
- Equine
By Distribution Channel:
- Veterinary Clinics
- Veterinary Hospitals
- Veterinary Research Institutes
- Retail Pharmacies
By Region:
- North America
- Latin America
- Western Europe
- Eastern Europe
- South Asia and Pacific
- East Asia
- The Middle East and Africa
Author By:
Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.
Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.
Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube